IFF Invests $30 Million to Expand Regional Footprint in Singapore
New innovation center and Singapore Flexiblend plant to accelerate innovation and broaden co-creation capabilities in Greater Asia
Find out moreCatalysts for Good
Together, we can transform tomorrow
To do more good, it’s important to think about the bigger picture. That's why at IFF Health & Biosciences, we take a holistic approach to sustainable growth, enabling our customers to meet ESG goals and experience market success, while improving the environmental footprint and wellbeing of millions globally. See how together, we are Catalysts for Good.
To do more good, it’s important to think about the bigger picture. That's why at IFF Health & Biosciences, we take a holistic approach to sustainable growth, enabling our customers to meet ESG goals and experience market success, while improving the environmental footprint and wellbeing of millions globally. See how together, we are Catalysts for Good.
INNOVATION
At the forefront of modern biotechnology
With a broad biotech portfolio and a legacy of industry firsts, IFF Health & Biosciences works at the cutting-edge of biotechnology innovation, so our customers can stay ahead of market trends, creating industry-leading products that transform markets – and everyday lives.
Designed Enzymatic Biomaterials: Performance, Naturally Better
IFF Health & Biosciences has developed a technology platform called Designed Enzymatic Biomaterials, or "DEB". Leveraging deep expertise in biotech research, process development and product commercialization, we can now create polysaccharides from the enzymatic polymerization of simple sugars, which are highly-tailored for a range of applications in home and personal care—and beyond. Enzymatic polymerization represents an entirely new way to make high performing, sustainable materials, and its potential to transform markets is vast.
ASSETS
Investing in our business - and yours
To ensure that our customers have cutting-edge innovations and ample supply, we've recently invested over 200 million USD to enhance our global asset footprint. This includes the expansion of our facilities and opening new R&D and applications labs worldwide to satisfy local market demand.
IFF Invests $15.8 Million in New Innovation Centers in Latin America
IFF, an industry leader in solutions for food, beverages, health, biosciences, and scent, announced the company invested $15.8 million in three of its innovation centers in Latin America.
Find out moreIFF to Acquire Health Wright Products
The acquisition will bring formulation and finished format capabilities to IFF’s Health & Biosciences probiotics, natural extracts and botanicals businesses, allowing for innovation in custom formulation and combination products through joint capabilities.
Find out moreSustainability
Where sustainability and business go hand-in-hand
Inspired by nature, we channel our passion for bioscience into technologies that provide sustainable products and solutions across a broad range of industries. Our holistic approach enables our customers to meet their ESG goals as well as their customers’ and consumer demands.
Brewing the change, for good
Advances in technology and climate change requires innovation to find new ways of doing things. IFF is delivering this much-needed innovation for brewers and beverage companies to meet the desires and challenges of tomorrow’s brew. See how we're catalyzing the future of brewing, today.
IFF: Catalyzing the future of Brewing
CONNECT WITH US
#CatalystsForGood
Follow IFF Biosciences on LinkedIn for the latest stories on how we’re continuously advancing sustainable, socially-conscious innovation across all the industries we serve.
Follow IFF Biosciences on LinkedIn for the latest stories on how we’re continuously advancing sustainable, socially-conscious innovation across all the industries we serve.
